ALIGNMT AI Collaborates with Leading Global Cancer Center to Advance AI Governance in Healthcare

ALIGNMT joins the MSK Innovation Hub to Collaboratively Pilot its AI Governance Platform for Operationalizing MSK’s AI Lifecycle Management Framework

NEW YORK, Oct. 1, 2025 /PRNewswire/ — ALIGNMT AI, a leading platform for AI governance and risk monitoring, announced today a collaboration through the MSK Innovation Hub (iHub) at Memorial Sloan Kettering Cancer Center (MSK), one of the world’s leading cancer treatment and research institutions. The relationship will leverage ALIGNMT’s Governance Platform to enhance operationalization of key aspects of MSK’s responsible oncology AI governance processes.

The objectives of this collaboration are significant for healthcare institutions such as MSK, since the stakes for responsible AI deployment are particularly high.

As healthcare organizations encounter growing requirements to ensure effective oversight of AI technologies—both due to regulatory scrutiny and patient safety considerations—the collaboration between ALIGNMT AI and MSK iHub is intended to offer a model for responsible AI governance at scale.

“Healthcare leaders are recognizing that AI governance is no longer optional—it’s critical infrastructure that must layer seamlessly onto existing production workflows to enable real-time risk monitoring,” said Andreea Bodnari, CEO of ALIGNMT AI. “Working through the MSK iHub program will enable us to refine, scale, and potentially further develop the ALIGNMT governance solutions for the healthcare sector.”

“We’re excited to have ALIGNMT collaborate with us through the MSK iHub to advance the way MSK and other healthcare organizations leverage innovative technology solutions to reinforce and scale how ever-growing AI portfolios are managed,” said Rick Peng, Digital Ventures Lead in MSK’s Office of Entrepreneurship & Commercialization.

About ALIGNMT AI ALIGNMT AI provides comprehensive AI governance and risk management solutions that safeguard artificial intelligence across its entire lifecycle. The platform automates compliance workflows, continuous risk monitoring, and transparency reporting, transforming fragmented processes into a unified, scalable system. Certified by the Coalition for Healthcare AI and trusted by leading healthcare institutions, ALIGNMT AI helps organizations deploy AI responsibly while maintaining operational efficiency and patient safety. Learn more or request a demo at alignmt.ai.

View original content:https://www.prnewswire.com/news-releases/alignmt-ai-collaborates-with-leading-global-cancer-center-to-advance-ai-governance-in-healthcare-302568338.html

SOURCE ALIGNMT AI

Staff

Recent Posts

Is SynergyRx GLP-1 Legitimate? Platform Lists Compounded Semaglutide at $200 With Oral Tablet Options

Telehealth Provider Offers FDA-Approved and Compounded Weight Loss Medications in All 50 States, Subject to…

14 hours ago

Direct Meds GLP-1 Medications Platform Maintains LegitScript Certification as New Year Weight Loss Interest Peaks Amid Compounding Regulatory Shifts

Telehealth Platform Facilitates Compounded Semaglutide and Tirzepatide Access Through Licensed Provider Evaluation as FDA Shortage…

14 hours ago

Best Peptides for Boosting Growth Hormone: ReadyRx Lists Prescription Sermorelin in Injectable and Needle-Free Formats for 2026

Analysis examines best peptides for boosting growth hormone as ReadyRx lists prescription sermorelin in injectable…

14 hours ago

Best Fat Burner For Men 2026: Effective Fat Burning Supplements For Men’s Belly Fat Launched By Wolfson Brands Ltd

Discover the best fat burner for men in 2025. Explore Wolfson Brand’s effective fat-burning supplements…

15 hours ago

MEDIROM Partners with World

Deploying “Proof of Human” Infrastructure throughout Japan, a Technology Envisioned by Sam Altman and Alex…

15 hours ago